What’s to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?

References

• Lewy L. Paralysis agitans. In: I. Pathologische Anatomie. Lewandowsky’s Handbuch der Neurologie, 3 Band.
   Google Scholar
• Leverenz JB, Umar I, Wang Q, Montine TJ, McMillan PJ, Tsuang DW, et al. Proteomic identification of novel proteins in cortical lewy bodies. Brain Pathol 2007; 17:139 - 45; http://dx.doi.org/10.1111/j.1750-3639.2007.00048.x; PMID: 17388944
   PubMed Web of Science ®Google Scholar
• Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997; 388:839 - 40; http://dx.doi.org/10.1038/42166; PMID: 9278044
   PubMed Web of Science ®Google Scholar
• Jellinger KA. The role of α-synuclein in neurodegeneration — An update. Transl Neurosci. 2012; 3:75 - 122; http://dx.doi.org/10.2478/s13380-012-0013-1
   Web of Science ®Google Scholar
• Jo E, McLaurin J, Yip CM, St George-Hyslop P, Fraser PE. alpha-Synuclein membrane interactions and lipid specificity. J Biol Chem 2000; 275:34328 - 34; http://dx.doi.org/10.1074/jbc.M004345200; PMID: 10915790
   PubMed Web of Science ®Google Scholar
• Dikiy I, Eliezer D. Folding and misfolding of alpha-synuclein on membranes. Biochim Biophys Acta 2012; 1818:1013 - 8; http://dx.doi.org/10.1016/j.bbamem.2011.09.008; PMID: 21945884
   PubMed Web of Science ®Google Scholar
• Serpell LC, Berriman J, Jakes R, Goedert M, Crowther RA. Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation. Proc Natl Acad Sci U S A 2000; 97:4897 - 902; http://dx.doi.org/10.1073/pnas.97.9.4897; PMID: 10781096
   PubMed Web of Science ®Google Scholar
• Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, et al. alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 2002; 4:160 - 4; PMID: 11813001
   PubMed Web of Science ®Google Scholar
• Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 1997; 276:2045 - 7; http://dx.doi.org/10.1126/science.276.5321.2045; PMID: 9197268
   PubMed Web of Science ®Google Scholar
• Krüger R, Kuhn W, Müller T, Woitalla D, Graeber M, Kösel S, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson’s disease. Nat Genet 1998; 18:106 - 8; http://dx.doi.org/10.1038/ng0298-106; PMID: 9462735
   PubMed Web of Science ®Google Scholar
• Zarranz JJ, Alegre J, Gómez-Esteban JC, Lezcano E, Ros R, Ampuero I, et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 2004; 55:164 - 73; http://dx.doi.org/10.1002/ana.10795; PMID: 14755719
   PubMed Web of Science ®Google Scholar
• Chartier-Harlin M-C, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, et al. Alpha-synuclein locus duplication as a cause of familial Parkinson’s disease. Lancet 2004; 364:1167 - 9; http://dx.doi.org/10.1016/S0140-6736(04)17103-1; PMID: 15451224
   PubMed Web of Science ®Google Scholar
• Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, et al. alpha-Synuclein locus triplication causes Parkinson’s disease. Science 2003; 302:841; http://dx.doi.org/10.1126/science.1090278; PMID: 14593171
   PubMed Web of Science ®Google Scholar
• Fuchs J, Tichopad A, Golub Y, Munz M, Schweitzer KJ, Wolf B, et al. Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain. FASEB J 2008; 22:1327 - 34; http://dx.doi.org/10.1096/fj.07-9348com; PMID: 18162487
   PubMed Web of Science ®Google Scholar
• Chu Y, Kordower JH. Age-associated increases of α-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson’s disease?. Neurobiol Dis 2007; 25:134 - 49; http://dx.doi.org/10.1016/j.nbd.2006.08.021; PMID: 17055279
   PubMed Web of Science ®Google Scholar
• Li W, Lesuisse C, Xu Y, Troncoso JC, Price DL, Lee MK. Stabilization of alpha-synuclein protein with aging and familial parkinson’s disease-linked A53T mutation. J Neurosci 2004; 24:7400 - 9; http://dx.doi.org/10.1523/JNEUROSCI.1370-04.2004; PMID: 15317865
   PubMed Web of Science ®Google Scholar
• Collier TJ, Kanaan NM, Kordower JH. Ageing as a primary risk factor for Parkinson’s disease: evidence from studies of non-human primates. Nat Rev Neurosci 2011; 12:359 - 66; http://dx.doi.org/10.1038/nrn3039; PMID: 21587290
   PubMed Web of Science ®Google Scholar
• Olanow CW, Perl DP, DeMartino GN, McNaught KSP. Lewy-body formation is an aggresome-related process: a hypothesis. Lancet Neurol 2004; 3:496 - 503; http://dx.doi.org/10.1016/S1474-4422(04)00827-0; PMID: 15261611
   PubMed Web of Science ®Google Scholar
• Tanaka M, Kim YM, Lee G, Junn E, Iwatsubo T, Mouradian MM. Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective. J Biol Chem 2004; 279:4625 - 31; http://dx.doi.org/10.1074/jbc.M310994200; PMID: 14627698
   PubMed Web of Science ®Google Scholar
• Schapira AH, Jenner P. Etiology and pathogenesis of Parkinson’s disease. Mov Disord 2011; 26:1049 - 55; http://dx.doi.org/10.1002/mds.23732; PMID: 21626550
   PubMed Web of Science ®Google Scholar
• Lotharius J, Brundin P. Pathogenesis of Parkinson’s disease: dopamine, vesicles and α-synuclein. Nat Rev Neurosci 2002; 3:932 - 42; http://dx.doi.org/10.1038/nrn983; PMID: 12461550
   PubMed Web of Science ®Google Scholar
• Wersinger C, Sidhu A. Attenuation of dopamine transporter activity by alpha-synuclein. Neurosci Lett 2003; 340:189 - 92; http://dx.doi.org/10.1016/S0304-3940(03)00097-1; PMID: 12672538
   PubMed Web of Science ®Google Scholar
• Larsen KE, Schmitz Y, Troyer MD, Mosharov E, Dietrich P, Quazi AZ, et al. Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J Neurosci 2006; 26:11915 - 22; http://dx.doi.org/10.1523/JNEUROSCI.3821-06.2006; PMID: 17108165
   PubMed Web of Science ®Google Scholar
• Nemani VM, Lu W, Berge V, Nakamura K, Onoa B, Lee MK, et al. Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 2010; 65:66 - 79; http://dx.doi.org/10.1016/j.neuron.2009.12.023; PMID: 20152114
   PubMed Web of Science ®Google Scholar
• Lotharius J, O’Malley KL. The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity. J Biol Chem 2000; 275:38581 - 8; http://dx.doi.org/10.1074/jbc.M005385200; PMID: 10969076
   PubMed Web of Science ®Google Scholar
• Lee H-J, Baek SM, Ho D-H, Suk J-E, Cho E-D, Lee S-J. Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomers. Exp Mol Med 2011; 43:216 - 22; http://dx.doi.org/10.3858/emm.2011.43.4.026; PMID: 21415592
   PubMed Web of Science ®Google Scholar
• Conway KA, Rochet JC, Bieganski RM, Lansbury PT Jr.. Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 2001; 294:1346 - 9; http://dx.doi.org/10.1126/science.1063522; PMID: 11701929
   PubMed Web of Science ®Google Scholar
• Hsu LJ, Sagara Y, Arroyo A, Rockenstein E, Sisk A, Mallory M, et al. alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol 2000; 157:401 - 10; http://dx.doi.org/10.1016/S0002-9440(10)64553-1; PMID: 10934145
   PubMed Web of Science ®Google Scholar
• Cremades N, Cohen SIA, Deas E, Abramov AY, Chen AY, Orte A, et al. Direct observation of the interconversion of normal and toxic forms of α-synuclein. Cell 2012; 149:1048 - 59; http://dx.doi.org/10.1016/j.cell.2012.03.037; PMID: 22632969
   PubMed Web of Science ®Google Scholar
• Hashimoto M, Takeda A, Hsu LJ, Takenouchi T, Masliah E. Role of cytochrome c as a stimulator of alpha-synuclein aggregation in Lewy body disease. J Biol Chem 1999; 274:28849 - 52; http://dx.doi.org/10.1074/jbc.274.41.28849; PMID: 10506125
   PubMed Web of Science ®Google Scholar
• Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, et al. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 2000; 290:985 - 9; http://dx.doi.org/10.1126/science.290.5493.985; PMID: 11062131
   PubMed Web of Science ®Google Scholar
• Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD. Mitochondrial complex I deficiency in Parkinson’s disease. J Neurochem 1990; 54:823 - 7; http://dx.doi.org/10.1111/j.1471-4159.1990.tb02325.x; PMID: 2154550
   PubMed Web of Science ®Google Scholar
• Autere J, Moilanen JS, Finnilä S, Soininen H, Mannermaa A, Hartikainen P, et al. Mitochondrial DNA polymorphisms as risk factors for Parkinson’s disease and Parkinson’s disease dementia. Hum Genet 2004; 115:29 - 35; http://dx.doi.org/10.1007/s00439-004-1123-9; PMID: 15108120
   PubMed Web of Science ®Google Scholar
• Pyle A, Foltynie T, Tiangyou W, Lambert C, Keers SM, Allcock LM, et al. Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD. Ann Neurol 2005; 57:564 - 7; http://dx.doi.org/10.1002/ana.20417; PMID: 15786469
   PubMed Web of Science ®Google Scholar
• Valente EM, Arena G, Torosantucci L, Gelmetti V. Molecular pathways in sporadic PD. Parkinsonism Relat Disord 2012; 18:Suppl 1 S71 - 3; http://dx.doi.org/10.1016/S1353-8020(11)70023-2; PMID: 22166460
   PubMedGoogle Scholar
• Devi L, Raghavendran V, Prabhu BM, Avadhani NG, Anandatheerthavarada HK. Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem 2008; 283:9089 - 100; http://dx.doi.org/10.1074/jbc.M710012200; PMID: 18245082
   PubMed Web of Science ®Google Scholar
• Xie W, Chung KKK. Alpha-synuclein impairs normal dynamics of mitochondria in cell and animal models of Parkinson’s disease. J Neurochem 2012; 122:404 - 14; http://dx.doi.org/10.1111/j.1471-4159.2012.07769.x; PMID: 22537068
   PubMed Web of Science ®Google Scholar
• Calì T, Ottolini D, Negro A, Brini M. α-Synuclein controls mitochondrial calcium homeostasis by enhancing endoplasmic reticulum-mitochondria interactions. J Biol Chem 2012; 287:17914 - 29; http://dx.doi.org/10.1074/jbc.M111.302794; PMID: 22453917
   PubMed Web of Science ®Google Scholar
• Chinta SJ, Mallajosyula JK, Rane A, Andersen JK. Mitochondrial α-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo. Neurosci Lett 2010; 486:235 - 9; http://dx.doi.org/10.1016/j.neulet.2010.09.061; PMID: 20887775
   PubMed Web of Science ®Google Scholar
• Nakamura K, Nemani VM, Azarbal F, Skibinski G, Levy JM, Egami K, et al. Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. J Biol Chem 2011; 286:20710 - 26; http://dx.doi.org/10.1074/jbc.M110.213538; PMID: 21489994
   PubMed Web of Science ®Google Scholar
• Kamp F, Exner N, Lutz AK, Wender N, Hegermann J, Brunner B, et al. Inhibition of mitochondrial fusion by α-synuclein is rescued by PINK1, Parkin and DJ-1. EMBO J 2010; 29:3571 - 89; http://dx.doi.org/10.1038/emboj.2010.223; PMID: 20842103
   PubMed Web of Science ®Google Scholar
• Esteves AR, Arduíno DM, Swerdlow RH, Oliveira CR, Cardoso SM. Oxidative stress involvement in alpha-synuclein oligomerization in Parkinson’s disease cybrids. Antioxid Redox Signal 2009; 11:439 - 48; http://dx.doi.org/10.1089/ars.2008.2247; PMID: 18717628
   PubMed Web of Science ®Google Scholar
• Lema Tomé CM, Tyson T, Rey NL, Grathwohl S, Britschgi M, Brundin P. Inflammation and α-Synuclein’s Prion-like Behavior in Parkinson’s Disease-Is There a Link?. Mol Neurobiol 2012; http://dx.doi.org/10.1007/s12035-012-8267-8; PMID: 22544647
   PubMed Web of Science ®Google Scholar
• Abou-Sleiman PM, Healy DG, Quinn N, Lees AJ, Wood NW. The role of pathogenic DJ-1 mutations in Parkinson’s disease. Ann Neurol 2003; 54:283 - 6; http://dx.doi.org/10.1002/ana.10675; PMID: 12953260
   PubMed Web of Science ®Google Scholar
• Greggio E, Civiero L, Bisaglia M, Bubacco L. Parkinson’s disease and immune system: is the culprit LRRKing in the periphery?. J Neuroinflammation 2012; 9:94; http://dx.doi.org/10.1186/1742-2094-9-94; PMID: 22594666
   PubMed Web of Science ®Google Scholar
• Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML, et al. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson’s disease. FASEB J 2005; 19:533 - 42; http://dx.doi.org/10.1096/fj.04-2751com; PMID: 15791003
   PubMed Web of Science ®Google Scholar
• Theodore S, Cao S, McLean PJ, Standaert DG. Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease. J Neuropathol Exp Neurol 2008; 67:1149 - 58; http://dx.doi.org/10.1097/NEN.0b013e31818e5e99; PMID: 19018246
   PubMed Web of Science ®Google Scholar
• Rojanathammanee L, Murphy EJ, Combs CK. Expression of mutant alpha-synuclein modulates microglial phenotype in vitro. J Neuroinflammation 2011; 8:44; http://dx.doi.org/10.1186/1742-2094-8-44; PMID: 21554732
   PubMed Web of Science ®Google Scholar
• Watson MB, Richter F, Lee SK, Gabby L, Wu J, Masliah E, et al. Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein. Exp Neurol 2012; 237:318 - 34; http://dx.doi.org/10.1016/j.expneurol.2012.06.025; PMID: 22750327
   PubMed Web of Science ®Google Scholar
• Gao HM, Kotzbauer PT, Uryu K, Leight S, Trojanowski JQ, Lee VMY. Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration. J Neurosci 2008; 28:7687 - 98; http://dx.doi.org/10.1523/JNEUROSCI.0143-07.2008; PMID: 18650345
   PubMed Web of Science ®Google Scholar
• Vogiatzi T, Xilouri M, Vekrellis K, Stefanis L. Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J Biol Chem 2008; 283:23542 - 56; http://dx.doi.org/10.1074/jbc.M801992200; PMID: 18566453
   PubMed Web of Science ®Google Scholar
• Lynch-Day MA, Mao K, Wang K, Zhao M, Klionsky DJ. The role of autophagy in Parkinson’s disease. Cold Spring Harb Perspect Med 2012; 2:a009357; PMID: 22474616
   PubMed Web of Science ®Google Scholar
• Martinez-Vicente M, Talloczy Z, Kaushik S, Massey AC, Mazzulli J, Mosharov EV, et al. Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. J Clin Invest 2008; 118:777 - 88; PMID: 18172548
   PubMed Web of Science ®Google Scholar
• Xilouri M, Vogiatzi T, Vekrellis K, Park D, Stefanis L. Abberant α-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy. PLoS One 2009; 4:e5515; http://dx.doi.org/10.1371/journal.pone.0005515; PMID: 19436756
   PubMed Web of Science ®Google Scholar
• Yu WH, Dorado B, Figueroa HY, Wang L, Planel E, Cookson MR, et al. Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric α-synuclein. Am J Pathol 2009; 175:736 - 47; http://dx.doi.org/10.2353/ajpath.2009.080928; PMID: 19628769
   PubMed Web of Science ®Google Scholar
• Winslow AR, Chen C-W, Corrochano S, Acevedo-Arozena A, Gordon DE, Peden AA, et al. α-Synuclein impairs macroautophagy: implications for Parkinson’s disease. J Cell Biol 2010; 190:1023 - 37; http://dx.doi.org/10.1083/jcb.201003122; PMID: 20855506
   PubMed Web of Science ®Google Scholar
• Spencer B, Potkar R, Trejo M, Rockenstein E, Patrick C, Gindi R, et al. Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in α-synuclein models of Parkinson’s and Lewy body diseases. J Neurosci 2009; 29:13578 - 88; http://dx.doi.org/10.1523/JNEUROSCI.4390-09.2009; PMID: 19864570
   PubMed Web of Science ®Google Scholar
• Choubey V, Safiulina D, Vaarmann A, Cagalinec M, Wareski P, Kuum M, et al. Mutant A53T alpha-synuclein induces neuronal death by increasing mitochondrial autophagy. J Biol Chem 2011; 286:10814 - 24; http://dx.doi.org/10.1074/jbc.M110.132514; PMID: 21252228
   PubMed Web of Science ®Google Scholar
• Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rüb U. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson’s disease (preclinical and clinical stages). J Neurol 2002; 249:Suppl 3 III - , 1-5; http://dx.doi.org/10.1007/s00415-002-1301-4; PMID: 12528692
   PubMedGoogle Scholar
• Li J-Y, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, et al. Lewy bodies in grafted neurons in subjects with Parkinson’s disease suggest host-to-graft disease propagation. Nat Med 2008; 14:501 - 3; http://dx.doi.org/10.1038/nm1746; PMID: 18391963
   PubMed Web of Science ®Google Scholar
• Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson’s disease. Nat Med 2008; 14:504 - 6; http://dx.doi.org/10.1038/nm1747; PMID: 18391962
   PubMed Web of Science ®Google Scholar
• Brundin P, Li J-Y, Holton JL, Lindvall O, Revesz T. Research in motion: the enigma of Parkinson’s disease pathology spread. Nat Rev Neurosci 2008; 9:741 - 5; http://dx.doi.org/10.1038/nrn2477; PMID: 18769444
   PubMed Web of Science ®Google Scholar
• Brundin P, Kordower JH. Neuropathology in transplants in Parkinson’s disease: Implications for disease pathogenesis and the future of cell therapy. Waxman S, Stein DG, Swaab D, Fields H. Elsevier BV, 2012. 217-237.
   Google Scholar
• Dunning CJR, Reyes JF, Steiner JA, Brundin P. Can Parkinson’s disease pathology be propagated from one neuron to another?. Prog Neurobiol 2012; 97:205 - 19; http://dx.doi.org/10.1016/j.pneurobio.2011.11.003; PMID: 22115849
   PubMed Web of Science ®Google Scholar
• Hawkes CH, Del Tredici K, Braak H. Parkinson’s disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol 2007; 33:599 - 614; http://dx.doi.org/10.1111/j.1365-2990.2007.00874.x; PMID: 17961138
   PubMed Web of Science ®Google Scholar
• Angot E, Steiner JA, Lema Tomé CM, Ekström P, Mattsson B, Björklund A, et al. Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons in vivo. PLoS One 2012; 7:e39465; http://dx.doi.org/10.1371/journal.pone.0039465; PMID: 22737239
   PubMed Web of Science ®Google Scholar
• Kordower JH, Dodiya HB, Kordower AM, Terpstra B, Paumier K, Madhavan L, et al. Transfer of host-derived α synuclein to grafted dopaminergic neurons in rat. Neurobiol Dis 2011; 43:552 - 7; http://dx.doi.org/10.1016/j.nbd.2011.05.001; PMID: 21600984
   PubMed Web of Science ®Google Scholar
• Luk KC, Kehm VM, Zhang B, O’Brien P, Trojanowski JQ, Lee VM-Y. Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice. J Exp Med 2012; 209:975 - 86; http://dx.doi.org/10.1084/jem.20112457; PMID: 22508839
   PubMed Web of Science ®Google Scholar
• Mougenot A-L, Nicot S, Bencsik A, Morignat E, Verchère J, Lakhdar L, et al. Prion-like acceleration of a synucleinopathy in a transgenic mouse model. Neurobiol Aging 2012; 33:2225 - 8; http://dx.doi.org/10.1016/j.neurobiolaging.2011.06.022; PMID: 21813214
   PubMed Web of Science ®Google Scholar
• Lee H-J, Suk J-E, Lee K-W, Park S-H, Blumbergs PC, Gai W-P, et al. Transmission of Synucleinopathies in the Enteric Nervous System of A53T Alpha-Synuclein Transgenic Mice. Exp Neurobiol 2011; 20:181 - 8; http://dx.doi.org/10.5607/en.2011.20.4.181; PMID: 22355263
   PubMedGoogle Scholar
• Shannon KM, Keshavarzian A, Mutlu E, Dodiya HB, Daian D, Jaglin JA, et al. Alpha-synuclein in colonic submucosa in early untreated Parkinson’s disease. Mov Disord 2012; 27:709 - 15; http://dx.doi.org/10.1002/mds.23838; PMID: 21766334
   PubMed Web of Science ®Google Scholar
• Chanut F. Your synapse or mine? Promiscuous protein exchanges between neighboring synapses. PLoS Biol 2006; 4:e297; http://dx.doi.org/10.1371/journal.pbio.0040297; PMID: 20076633
   PubMedGoogle Scholar
• Broadwell RD, Balin BJ. Endocytic and exocytic pathways of the neuronal secretory process and trans-synaptic transfer of wheat germ agglutinin-horseradish peroxidase in vivo. J Comp Neurol 1985; 242:632 - 50; http://dx.doi.org/10.1002/cne.902420410; PMID: 2418083
   PubMed Web of Science ®Google Scholar
• Mathivanan S, Fahner CJ, Reid GE, Simpson RJ. ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res 2012; 40:Database issue D1241 - 4; http://dx.doi.org/10.1093/nar/gkr828; PMID: 21989406
   PubMed Web of Science ®Google Scholar
• Marzo L, Gousset K, Zurzolo C. Multifaceted roles of tunneling nanotubes in intercellular communication. Front Physiol 2012; 3:72; http://dx.doi.org/10.3389/fphys.2012.00072; PMID: 22514537
   PubMedGoogle Scholar
• Luk KC, Song C, O’Brien P, Stieber A, Branch JR, Brunden KR, et al. Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci U S A 2009; 106:20051 - 6; PMID: 19892735
   PubMed Web of Science ®Google Scholar
• Volpicelli-Daley LA, Luk KC, Patel TP, Tanik SA, Riddle DM, Stieber A, et al. Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 2011; 72:57 - 71; http://dx.doi.org/10.1016/j.neuron.2011.08.033; PMID: 21982369
   PubMed Web of Science ®Google Scholar
• Luk KC, Kehm VM, Carroll J, Zhang B, O’Brien P, Trojanowski JQ, et al. Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 2012; 338:949 - 53; http://dx.doi.org/10.1126/science.1227157; PMID: 23161999
   PubMed Web of Science ®Google Scholar
• Editorial. State of aggregation. Nature Publishing Group 2011; 14:399
   Google Scholar
• Aguzzi A, Sigurdson C, Heikenwaelder M. Molecular mechanisms of prion pathogenesis. Annu Rev Pathol 2008; 3:11 - 40; http://dx.doi.org/10.1146/annurev.pathmechdis.3.121806.154326; PMID: 18233951
   PubMed Web of Science ®Google Scholar
• Savica R, Rocca WA, Ahlskog JE. When does Parkinson disease start?. Arch Neurol 2010; 67:798 - 801; http://dx.doi.org/10.1001/archneurol.2010.135; PMID: 20625084
   PubMed Web of Science ®Google Scholar
• Jellinger KA. A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders. Biochim Biophys Acta 2009; 1792:730 - 40; http://dx.doi.org/10.1016/j.bbadis.2008.07.006; PMID: 18718530
   PubMed Web of Science ®Google Scholar
• Double KL, Reyes S, Werry EL, Halliday GM. Selective cell death in neurodegeneration: why are some neurons spared in vulnerable regions?. Prog Neurobiol 2010; 92:316 - 29; http://dx.doi.org/10.1016/j.pneurobio.2010.06.001; PMID: 20541584
   PubMed Web of Science ®Google Scholar